OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Updates on Systemic Therapy for Hepatocellular Carcinoma
Panagiotis Ntellas, Ian Chau
American Society of Clinical Oncology Educational Book (2024) Vol. 44, Iss. 1
Open Access | Times Cited: 26
Panagiotis Ntellas, Ian Chau
American Society of Clinical Oncology Educational Book (2024) Vol. 44, Iss. 1
Open Access | Times Cited: 26
Showing 1-25 of 26 citing articles:
Emerging targets in lipid metabolism for cancer therapy
Alexander R. Terry, Nissim Hay
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 6, pp. 537-551
Open Access | Times Cited: 21
Alexander R. Terry, Nissim Hay
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 6, pp. 537-551
Open Access | Times Cited: 21
Biomarker discovery in hepatocellular carcinoma (HCC) for personalized treatment and enhanced prognosis
Baofa Yu, Wenxue Ma
Cytokine & Growth Factor Reviews (2024) Vol. 79, pp. 29-38
Closed Access | Times Cited: 10
Baofa Yu, Wenxue Ma
Cytokine & Growth Factor Reviews (2024) Vol. 79, pp. 29-38
Closed Access | Times Cited: 10
Epidemiology of Hepatocellular Carcinoma in Taiwan
Yu‐Wei Lai, Ching‐Hu Chung
Clinics and Practice (2024) Vol. 14, Iss. 2, pp. 570-578
Open Access | Times Cited: 5
Yu‐Wei Lai, Ching‐Hu Chung
Clinics and Practice (2024) Vol. 14, Iss. 2, pp. 570-578
Open Access | Times Cited: 5
Prevalence of medical conditions or comorbidities influencing first-line therapy in unresectable hepatocellular carcinoma in the United States
Tammy A. Schuler, Shital Kamble, Kaushal Desai, et al.
Future Oncology (2025) Vol. 21, Iss. 3, pp. 313-319
Open Access
Tammy A. Schuler, Shital Kamble, Kaushal Desai, et al.
Future Oncology (2025) Vol. 21, Iss. 3, pp. 313-319
Open Access
Impact of Immunotherapy on the Care Patterns and Outcomes of Patients with Advanced Hepatocellular Carcinoma
Aryanna Sousa, Qusai AlMasad, Paola Pena, et al.
Clinics and Research in Hepatology and Gastroenterology (2025), pp. 102542-102542
Closed Access
Aryanna Sousa, Qusai AlMasad, Paola Pena, et al.
Clinics and Research in Hepatology and Gastroenterology (2025), pp. 102542-102542
Closed Access
National Survey of Real‐World Australian Treatment Patterns for Patients With Very‐Early‐To Intermediate‐Stage Hepatocellular Carcinoma
Stuart K. Roberts, Ammar Majeed, Kiran Rasaratnam, et al.
Cancer Medicine (2025) Vol. 14, Iss. 5
Open Access
Stuart K. Roberts, Ammar Majeed, Kiran Rasaratnam, et al.
Cancer Medicine (2025) Vol. 14, Iss. 5
Open Access
QSAR-Based Drug Repurposing and RNA-Seq Metabolic Networks Highlight Treatment Opportunities for Hepatocellular Carcinoma Through Pyrimidine Starvation
Nicholas Dale D. Talubo, Estela Máris Amorim Cruz, Peter Matthew Paul Fowler, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 903-903
Open Access
Nicholas Dale D. Talubo, Estela Máris Amorim Cruz, Peter Matthew Paul Fowler, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 903-903
Open Access
Impact of Sustained Virological Response on Long-Term Outcomes After Curative Resection in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma in the Era of Direct-Acting Antiviral Therapy
Hayato Abe, Yukiyasu Okamura, Nao Yoshida, et al.
Annals of Surgical Oncology (2024)
Closed Access | Times Cited: 3
Hayato Abe, Yukiyasu Okamura, Nao Yoshida, et al.
Annals of Surgical Oncology (2024)
Closed Access | Times Cited: 3
Ternary complex of Kaempferol-Hydroxypropyl-β-Cyclodextrin-Liposomes against hepatocellular carcinoma: Preparation, validation, pharmacokinetics and efficacy studies
Sunil Kumar Sah, Sama Ajay, Asawari Dilip Donadkar, et al.
International Journal of Pharmaceutics (2025), pp. 125261-125261
Closed Access
Sunil Kumar Sah, Sama Ajay, Asawari Dilip Donadkar, et al.
International Journal of Pharmaceutics (2025), pp. 125261-125261
Closed Access
Comparison of efficacy and safety of adjuvant therapies versus sorafenib in hepatocellular carcinoma: a systematic review and network meta-analysis
Wenying Quan, Hanifah Fazlin Zulkifli, Nazamid Saari, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Wenying Quan, Hanifah Fazlin Zulkifli, Nazamid Saari, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
The use of machine learning in transarterial chemoembolisation/transarterial embolisation for patients with intermediate-stage hepatocellular carcinoma: a systematic review
Lakshya Soni, Jasen Soopramanien, Amish Acharya, et al.
La radiologia medica (2025)
Open Access
Lakshya Soni, Jasen Soopramanien, Amish Acharya, et al.
La radiologia medica (2025)
Open Access
A conceptual exploration on the synergistic anti-tumor effects of high-order combination of OHSV2-DSTEFAP5/CD3, CAR-T cells, and immunotoxins in hepatocellular carcinoma
Shuang Dong, Xin Chen, Xiaoyu Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Shuang Dong, Xin Chen, Xiaoyu Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Treatment options for advanced hepatocellular carcinoma: the potential of biologics
Federico Rossari, Silvia Foti, Silvia Camera, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 6, pp. 455-470
Closed Access | Times Cited: 2
Federico Rossari, Silvia Foti, Silvia Camera, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 6, pp. 455-470
Closed Access | Times Cited: 2
Liver cell cancer surveillance practice in Nigeria: Pitfalls and future prospects
Musa Yusuf, Ifeorah Ijeoma, Abubakar Sadiq Maiyaki, et al.
World Journal of Hepatology (2024) Vol. 16, Iss. 10, pp. 1132-1141
Open Access | Times Cited: 2
Musa Yusuf, Ifeorah Ijeoma, Abubakar Sadiq Maiyaki, et al.
World Journal of Hepatology (2024) Vol. 16, Iss. 10, pp. 1132-1141
Open Access | Times Cited: 2
Current Treatment Methods in Hepatocellular Carcinoma
Katherine Krupa, Marta Fudalej, Anna Cencelewicz-Lesikow, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 4059-4059
Open Access | Times Cited: 2
Katherine Krupa, Marta Fudalej, Anna Cencelewicz-Lesikow, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 4059-4059
Open Access | Times Cited: 2
Prolonged Complete Remission Using Tislelizumab for Hepatocellular Carcinoma After Adjuvant Chemotherapy Failure: A Case Report
Xianmin Zhu, Shuang Dong, Jing Tang, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 1005-1013
Open Access | Times Cited: 1
Xianmin Zhu, Shuang Dong, Jing Tang, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 1005-1013
Open Access | Times Cited: 1
Engineering HBV-specific T cells for treatment of HBV-related HCC and HBV infection: past, present and future
Antonio Bertoletti, Anthony T. Tan
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 4, pp. 728-734
Open Access | Times Cited: 1
Antonio Bertoletti, Anthony T. Tan
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 4, pp. 728-734
Open Access | Times Cited: 1
Sorafenib plus memory-like natural killer cell immunochemotherapy boosts treatment response in liver cancer
Aydιn Eresen, Zigeng Zhang, Guangbo Yu, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Aydιn Eresen, Zigeng Zhang, Guangbo Yu, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Lenvatinib versus sorafenib second-line therapy in patients with hepatocellular carcinoma progressed to atezolizumab plus bevacizumab: a retrospective real-world study
Mara Persano, Andrea Casadei‐Gardini, Toshifumi Tada, et al.
Oncology (2024), pp. 1-13
Closed Access | Times Cited: 1
Mara Persano, Andrea Casadei‐Gardini, Toshifumi Tada, et al.
Oncology (2024), pp. 1-13
Closed Access | Times Cited: 1
Computational and experimental advances in liver-on-a-chip technology for cancer research: a systematic review
Violeta Carvalho, Mariana Ferreira, Raquel O. Rodrigues, et al.
Biophysical Reviews (2024) Vol. 17, Iss. 1, pp. 151-167
Open Access | Times Cited: 1
Violeta Carvalho, Mariana Ferreira, Raquel O. Rodrigues, et al.
Biophysical Reviews (2024) Vol. 17, Iss. 1, pp. 151-167
Open Access | Times Cited: 1
Survival benefit of living donor liver transplant for patients with hepatocellular carcinoma
Sarah R. Kaslow, Alejandro Torres-Hernandez, Feng Su, et al.
Updates in Surgery (2024)
Closed Access
Sarah R. Kaslow, Alejandro Torres-Hernandez, Feng Su, et al.
Updates in Surgery (2024)
Closed Access
Systemic treatment of hepatocellular carcinoma secondary to non-alcoholic fatty liver disease
Karolina Rzeniewicz, Rohini Sharma
World Journal of Clinical Oncology (2024) Vol. 15, Iss. 11, pp. 1394-1403
Closed Access
Karolina Rzeniewicz, Rohini Sharma
World Journal of Clinical Oncology (2024) Vol. 15, Iss. 11, pp. 1394-1403
Closed Access
Association of IL-6 G-174C (rs1800795) variant with the susceptibility to hepatocellular carcinoma in patients with chronic hepatitis
Eman H. Abuelnadar, Lamiaa Mohamed Mahmoud Ramadan, Hanaa Elsayed Ahmed Shahin, et al.
Journal of the Egyptian National Cancer Institute (2024) Vol. 36, Iss. 1
Open Access
Eman H. Abuelnadar, Lamiaa Mohamed Mahmoud Ramadan, Hanaa Elsayed Ahmed Shahin, et al.
Journal of the Egyptian National Cancer Institute (2024) Vol. 36, Iss. 1
Open Access
Changing treatment patterns for hepatocellular carcinoma: A Surveillance, Epidemiology, and End Results–Medicare study
Franklin Iheanacho, Angela C. Tramontano, Thomas A. Abrams, et al.
Cancer (2024)
Closed Access
Franklin Iheanacho, Angela C. Tramontano, Thomas A. Abrams, et al.
Cancer (2024)
Closed Access
Liver cell cancer surveillance practice in Nigeria: Pitfalls and future prospects
Musa Yusuf, Ifeorah Ijeoma, Abubakar Sadiq Maiyaki, et al.
World Journal of Hepatology (2024) Vol. 16, Iss. 10, pp. 1312-1321
Open Access
Musa Yusuf, Ifeorah Ijeoma, Abubakar Sadiq Maiyaki, et al.
World Journal of Hepatology (2024) Vol. 16, Iss. 10, pp. 1312-1321
Open Access
